Author/Creator: Rawley, O. - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Rawley, O.

1. Lenalidomide as a novel treatment for refractory acquired von Willebrand syndrome associated with monoclonal gammopathy. (27th April 2016)

Authors:: Lavin, M.; Brophy, T. M.; Rawley, O.; O'Sullivan, J. M.; Hayden, P. J.; Browne, P. V.; Ryan, K.; O'Connell, N.; O'Donnell, J. S.
Journal:: Journal of thrombosis and haemostasis
Issue:: Volume 14:Number 6(2016:Jun.)
Page Start:: 1200
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. N‐linked glycan truncation causes enhanced clearance of plasma‐derived von Willebrand factor. (9th December 2016)

Authors:: O'Sullivan, J. M.; Aguila, S.; McRae, E.; Ward, S. E.; Rawley, O.; Fallon, P. G.; Brophy, T. M.; Preston, R. J. S.; Brady, L.; Sheils, O.; Chion, A.; O'Donnell, J. S.
Journal:: Journal of thrombosis and haemostasis
Issue:: Volume 14:Number 12(2016:Dec.)
Page Start:: 2446
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Von Willebrand factor arginine 1205 substitution results in accelerated macrophage‐dependent clearance in vivo. (13th April 2015)

Authors:: Rawley, O.; O'Sullivan, J. M.; Chion, A.; Keyes, S.; Lavin, M.; van Rooijen, N.; Brophy, T. M.; Fallon, P.; Preston, R. J. S.; O'Donnell, J. S.
Journal:: Journal of thrombosis and haemostasis
Issue:: Volume 13:Number 5(2015:May)
Page Start:: 821
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗